WO2008098001A2 - Removable intramuscular electrode - Google Patents
Removable intramuscular electrode Download PDFInfo
- Publication number
- WO2008098001A2 WO2008098001A2 PCT/US2008/053086 US2008053086W WO2008098001A2 WO 2008098001 A2 WO2008098001 A2 WO 2008098001A2 US 2008053086 W US2008053086 W US 2008053086W WO 2008098001 A2 WO2008098001 A2 WO 2008098001A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrode
- tether
- tissue
- electrical lead
- lead
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
Definitions
- the invention relates to intramuscular electrodes, such as diaphragm pacing electrodes.
- Intramuscular diaphragm pacing stimulation has been shown to be a viable therapeutic technique for replacement of chronic mechanical ventilation in patients with respiratory insufficiency, such as high-level spinal cord injury. DPS has also been demonstrated to have a clinically relevant effect in conditioning the diaphragm of patients with amyotrophic lateral sclerosis.
- These therapeutic applications of electrodes are ones in which the electrode are typically designed to be implanted for duration of the life of the patient or until mechanical failure of the electrode. Therefore, the electrodes are typically constructed with significant redundancy, reinforcement, and barbing to promote longevity and stabilization in the target muscle.
- intramuscular electrodes have been developed for shorter-term applications.
- intramuscular, percutaneous, single-helix design electrodes have been used for functional electrical stimulation in applications where the electrode is placed through a percutaneous needle insertion into the target muscle.
- These electrodes are typically removed by pulling axially on the electrode lead.
- the barbs on the electrodes, as well as fibrosis and encapsulation of the electrode by the surrounding tissue frequently resist or complicate removal of the electrodes.
- the electrodes and/or the wires extending proximally from them therefore frequently break during removal, thus leaving the electrode or a portion thereof in the muscle or subcutaneous tissue, as well as creating an undesirable level of tissue disturbance.
- intramuscular electrodes that have not yet been fully met by available products. Most basically, intramuscular electrodes need to meet the design criteria of being able to deliver the desired level of stimulus to target tissue, and be able to mechanically survive such use. If extraction of the electrode is necessary, it is an advantage for the electrode to survive extraction without breaking apart and generating "unretrieved device fragments" (UDFs).
- UDFs unretrieved device fragments
- UDFs are a serious hazard; the FDA health notifications report about 1000 adverse events per year that are related to UDFs. Additionally, the extraction undesirably and almost inevitably visits at least some trauma upon the target tissue. Data have shown that extractions of simple intramuscular helical electrodes (Case Western Reserve University type) result in a fracture rate of 53% of electrodes with known status of integrity recorded (Knutson et ah, "Electrode fracture rates and occurrences of infection and granuloma associated with percutaneous intramuscular electrodes in upper-limb functional electrical stimulation applications," / Rehab Res. & Dev., vol. 39, no. 6, pp. 671-83 (Nov/Dec 2002)).
- the invention is a removable, percutaneous electrode that may be implanted into muscle tissue using laparoscopic, thorascopic, or open surgical techniques.
- the invention relates to a medical electrode system that includes a removably-implantable electrode and methods of using the system, such methods being summarized below after first summarizing the system.
- the medical electrode system includes an electrode, an electrical lead mechanically and electrically connected to the electrode and extending proximally from the electrode, and an electrode tether bonded to the electrode and extending proximally from the electrode.
- the medical electrode system may further include a tissue-piercing guide attached to the distal end of the electrode; and in some of these embodiments the tissue piercing guide may include a needle having a flared proximal end and a sharp distal end.
- the electrical lead surrounds at least a portion of the tether.
- the electrical lead of the system includes an insulated conductor, and the electrode includes an uninsulated portion of the conductor.
- the medical electrode system may further include an electrical connector attached to a proximal end of the electrical lead, and the electrical connector may be mechanically attached to the tether.
- the medical electrode system may further include a flexible barb.
- the tether includes a core that extends through the electrical lead and the electrode, m some of these embodiments that core does not extend through the barb. In some embodiments of the system, the core is connected to the tissue-piecing guide.
- the tissue-piercing guide comprises a needle, and in some of these embodiments, the needle may have a flared proximal end and a sharp distal end
- the core may include a distally terminal knob positioned distal to the electrode; the knob being configured to engage a delivery instrument to facilitate ejection of the electrode from the instrument.
- a method of using an electrode in target tissue in a patient includes inserting a tissue-piercing guide into and through the target tissue, pulling an electrode connected to a proximal end of the tissue-piercing guide into the target tissue (the electrode being connected to the tissue-piercing guide by a tether extending distally from the electrode), and extendmg an electrical lead and the tether proximally from the electrode to an electrical connection location.
- the electrode includes a barb
- the method includes pulling the barb into the target tissue
- Method embodiments of using the electrode may further include cutting the tether between the electrode and the tissue-piercing guide after the pulling step, and removing the tissue- piercmg guide from the patient.
- the method may also further include removing the electrode from the target tissue; the removing step may include pulling proximally on the electrical lead and pulling proximally on the tether.
- the electrical lead and the tether terminate in an electrical connector, and with these embodiments, the step of removing step may further include removing the electrical connector from the electrical lead and tether.
- the electrical lead surrounds at least a portion of the tether, and with these embodiments, the step of removing the electrode may further include separating the electrical lead and the tether prior to the pulling steps.
- the method includes inserting an electrode into the target tissue (the electrode being bonded to a tether and electrically connected to an electrical lead), and extending an electrical lead and the tether proximally from the electrode to an electrical connection location.
- the method may further include removing the electrode from the target tissue, in which case the removing step includes pulling proximally on the electrical lead and pulling proximally on the tether.
- the electrical lead and tether terminate in an electrical connecter, and in such embodiments the removing step may further include removing the electrical connector from the electrical lead and tether.
- the electrical lead surrounds at least a portion of the tether, and in such embodiments, the removing step may further include separating the electrical lead and the tether prior to the pulling steps.
- Figure 1 is a side elevational view of an intramuscular electrode according to one embodiment of the invention.
- Figure 2 is a side elevational view of an intramuscular electrode according to a second embodiment of the invention.
- Figure 3 is a side elevational view of an intramuscular electrode according to a third embodiment of the invention.
- FIG. 1 shows one embodiment of an electrode system of this invention, which includes electrode 10 and electrode lead 12 formed from a helically wound insulated conductor. In some other embodiments, two helically interwoven conductors form the lead and electrode. The insulation has been removed from the part of the conductor, thus forming electrode 10, while the insulation covering the lead portion 12 remains intact. Electrode 10 is bent bac ⁇ to form a barb 14 as shown Electrode 10 and lead 12 terminate proximally in a connector 16 that may be connector to an exterior stimulator cable providing stimulation pulses through the lead to the electrode after the electrode has been implanted As shown, connector 16 has a sleeve 18 covering the electrical connection between lead 12 and a connector pin 20. Sleeve 18 may also provide strain relief.
- a tether formed, for example, as a core 22, is disposed withm the helix of lead 12 and electrode 10
- the core 22 may be formed of a variety of materials, for example polypropylene suture material, absorbable suture material or any other suitable material. Core 22 being flexible, it imparts flexibility to the electrode as a whole. Core 22 is p ⁇ ma ⁇ ly attached or bonded to electrode 10, but the core's attachment may extend to or through the length of lead 12. Attachment of the core, at the site of electrode 10, may be performed by a mechanical heating that results m an infiltration and expansion of the core material into the electrode windings.
- the attachment between the core and the electrical lead is achieved by heating the core and electrode so that the polypropylene expands within the helix of electrode 10.
- core 22 extends only through the portion of the electrode that is in line with lead 12 and does not extend into barb 14. In other embodiments, the core may extend throughout the entire electrode.
- the electrode may be attached to the core in other ways as well, such as by crimping.
- the proximal end of core 22 is attached to a connector 16, such as by crimping.
- the electrode of this invention may be delivered and implanted into muscle tissue by any conventional means
- the embodiments shown in figures 1 - 3 depict an electrode implantation device that is integrated with the electrode and lead.
- core 22 extends through and past electrode 10 to a tissue-piercmg guide, such as a needle 30.
- Needle 30 is attached to core 22 by crimping or by some other suitable means.
- needle 30 has a curved tip 32 at its distal end to facilitate insertion into and out of muscle, particularly thick muscle.
- the proximal end of needle 30 has the same diameter as the needle shaft.
- the proximal end of the needle 30 may be flared to create an opening and facilitate entry of the electrode through the target tissue (such as the epimysium and muscle fibers of the diaphragm).
- the size of the needle depends on the application and/or site to which the electrode is being directed
- suitable needle sizes range from 28 gauge to 16 gauge. Other applications may require other needle sizes either larger or smaller.
- the shaft of needle 30 is typically longer than the length of the de-insulated electrode.
- the portion of electrode 10 in line with lead 12 may have a length of about 10 mm, while barb 14 may have a length of about 5 mm.
- the shaft of needle 30 may be about 20 mm long, and the curved tip 32 may extend about 2.5 mm up from the needle shaft axis.
- the portion of core 22 extending past electrode 10 to needle 30 is about 20 mm.
- FIG. 2 shows another embodiment that includes an implantation needle 30 with a straight tip 34 All other elements of the invention are the same as the figure 1 embodiment and are labeled accordingly.
- This straight-tip needle may be used for thinner muscle or for other tissue so that as the needle is inserted into the tissue at a shallow angle, the tip does not emerge from the tissue before a proper distance has been traversed by the needle.
- the needle may have an alternate shape (such as an intermediate inflection point) to facilitate tissue entry without prematurely emerging from the tissue until an appropriate or sufficient distance has been traversed by the needle
- the needle 30 When implanting the electrode of figure 1 or figure 2 into a target tissue site such as the diaphragm, the needle 30 is inserted and guided laparoscopically into the abdomen below the diaphragm at the desired implant location.
- the appropriate electrode implant locations may be determined using the mapping procedure described by Onders, et ai, "Mapping the phrenic nerve motor point' the key to a successful laparoscopic diaphragm pacing system in the first human series " Surgery 136(4). 819-26, 2004.) Implantation may also occur above the diaphragm using thoracoscopic techniques, or it may also occur above or below the diaphragm using open surgical techniques.
- the curved distal tip 32 of the needle is passed into the diaphragm, and then guided out (like a sewing needle) at a point preferably at least about 10 mm distal to the entry point.
- the needle is advanced further distally to pull or embed the electrode 10 mto the diaphragm tissue.
- the heat bonding between core 22 and electrode 10 helps ensure that the electrode will advance into the tissue without sliding back on the lead when encountering tissue resistance.
- Electrode barb 14 folds back toward the linear axis of the device as the electrode is advanced distally into the tissue, but prevents the electrode from being easily pulled back proximally.
- Connector 16 and the proximal end of lead 12 may be tunneled subcutaneously before exiting through the patient's skin via a needle (or trocar) puncture to provide a connection to an external stimulator.
- core 22 may be cut between the proxnnal end of needle 30 and the core's exit point from the diaphragm, and the needle may be removed from the patient.
- FIG. 3 shows another embodiment of electrode system that is similar to the embodiments of figures 1 and 2 except that it lacks the implantation needle and has instead a knob 25. All other elements of the device of identical to those of figures 1 and 2 and labeled accordingly.
- Knob 25 may be formed by melting the distal terminal portion of the core, or it may be formed by any suitable method or fo ⁇ ned of any suitable material such that it is firmly bonded to the core 22 or integral with the core 22 This particular embodiment is approp ⁇ ate for use in conjunction with a surgical instrument for implanting electrodes such as that described in U.S. Patent No.
- the knob 25 may be finished flush with the electrode 10 to provide a feature with which the instrument can engage to facilitate ejection of the electrode and lead from the surgical instrument, and in so doing, insert the electrode system into the target site.
- diaphragm pacing may be performed for a finite pe ⁇ od of time. For example, diaphragm pacing may help wean patients from mechanical ventilation sooner and more easily than could otherwise be weaned. Once diaphragm pacing is no longer needed, removal of the electrode and lead from the patient's diaphragm and abdomen is desired.
- connector 16 is first cut off the proximal end of lead 12. Since core 22 is bound to connector 16 but is not bound to the insulated portion of lead 12, cutting off the connector allows the proximal ends of core 22 and lead 12 to be moved independently. Helical lead 12 may then be straightened, or unwound from around the core and pulled proxrmally to dislodge electrode 10 from the tissue. Concurrently, core 22 may be pulled proximally as well, independently of lead 12. The combination of the pulling effects of the lead and the core helps the electrode become dislodged from the tissue despite any encapsulation or fibrosis around the electrode. In addition, the electrode barb 14 may straighten in response to sufficient proximal force to allow the electrode to exit the tissue more easily.
Abstract
An implantable medical electrode system for intramuscular use that is readily removable is provided, as well as methods for its use. The system includes an electrode, an electrical lead mechanically and electrically connected to the electrode and extending proximally, and a tether bonded to the electrode and extending proximally. A conductor with an insulated portion enwraps the electrical lead; an uninsulated portion enwraps the electrode. Some embodiments may include a tissue-piercing guide such as a needle. In some embodiments, the electrode includes a barb, although m some of these embodiments the tether does not extend through the barb. The method of using the system includes inserting the through a target tissue, pulling the electrode with the needle into the target tissue, and extending the electrical lead and tether proximally to an electrical connection. Methods are further provided for removing the electrode which take advantage of structural features of the system.
Description
REMOVABLE INTRAMUSCULAR ELECTRODE
REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U.S.C. § 119 to U.S. Provisional Patent Application No 60/899,799, filed on February 5, 2007, the disclosure of which is incorporated by reference.
INCORPORATION BY REFERENCE
[0002] All publications and patent applications mentioned m this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
FIELD OF THE INVENTION
[0003] The invention relates to intramuscular electrodes, such as diaphragm pacing electrodes.
BACKGROUND OF THE INVENTION
[0004] Intramuscular diaphragm pacing stimulation (DPS) has been shown to be a viable therapeutic technique for replacement of chronic mechanical ventilation in patients with respiratory insufficiency, such as high-level spinal cord injury. DPS has also been demonstrated to have a clinically relevant effect in conditioning the diaphragm of patients with amyotrophic lateral sclerosis. These therapeutic applications of electrodes are ones in which the electrode are typically designed to be implanted for duration of the life of the patient or until mechanical failure of the electrode. Therefore, the electrodes are typically constructed with significant redundancy, reinforcement, and barbing to promote longevity and stabilization in the target muscle.
[0005] Some intramuscular electrodes have been developed for shorter-term applications. For example, intramuscular, percutaneous, single-helix design electrodes have been used for functional electrical stimulation in applications where the electrode is placed through a percutaneous needle insertion into the target muscle. These electrodes are typically removed by pulling axially on the electrode lead. However, the barbs on the electrodes, as well as fibrosis and encapsulation of the electrode by the surrounding tissue, frequently resist or complicate removal of the electrodes. The electrodes and/or the wires extending proximally from them therefore frequently break during removal, thus leaving the electrode or a portion thereof in the muscle or subcutaneous tissue, as well as creating an undesirable level of tissue disturbance. See Peterson et al., "Long-Term Intramuscular Electrical Activation of the Phrenic Nerve: Safety and Reliability," IEEE Trans Biomed. Eng., vol. 41, no. 12 pp. 1115-26 (Dec. 1994).
[0006] A number of design features are desirable in intramuscular electrodes that have not yet been fully met by available products. Most basically, intramuscular electrodes need to meet the design criteria of being able to deliver the desired level of stimulus to target tissue, and be able to mechanically survive such use. If extraction of the electrode is necessary, it is an advantage for the electrode to survive extraction without breaking apart and generating "unretrieved device fragments" (UDFs). UDFs are a serious hazard; the FDA health notifications report about 1000 adverse events per year that are related to UDFs. Additionally, the extraction undesirably and almost inevitably visits at least some trauma upon the target tissue. Data have shown that extractions of simple intramuscular helical electrodes (Case Western Reserve University type) result in a fracture rate of 53% of electrodes with known status of integrity recorded (Knutson et ah, "Electrode fracture rates and occurrences of infection and granuloma associated with percutaneous intramuscular electrodes in upper-limb functional electrical stimulation applications," / Rehab Res. & Dev., vol. 39, no. 6, pp. 671-83 (Nov/Dec 2002)). See also Bhadra et ah, "Extraction Force and Tissue Change During Removal of a Tined Intramuscular Electrode from Rat Gastrocnemius," Ann. Biomed. Eng , vol. 34, no. 6, pp. 1042-50 (June 2006).
SUMMARY OF THE INVENTION
[0007] For percutaneous muscle stimulation of a temporary or short-term duration, it is desirable to use electrodes that can be easily removed without significant trauma to the muscle or other surrounding tissue and without leaving portions of the electrode behind. The present invention provides such electrodes and a method of usmg such electrodes. In some embodiments, the invention is a removable, percutaneous electrode that may be implanted into muscle tissue using laparoscopic, thorascopic, or open surgical techniques.
[0008] The invention relates to a medical electrode system that includes a removably-implantable electrode and methods of using the system, such methods being summarized below after first summarizing the system. The medical electrode system includes an electrode, an electrical lead mechanically and electrically connected to the electrode and extending proximally from the electrode, and an electrode tether bonded to the electrode and extending proximally from the electrode. In some embodiments, the medical electrode system may further include a tissue-piercing guide attached to the distal end of the electrode; and in some of these embodiments the tissue piercing guide may include a needle having a flared proximal end and a sharp distal end.
[0009] In some embodiments of the medical electrode system, the electrical lead surrounds at least a portion of the tether. The electrical lead of the system includes an insulated conductor, and the electrode includes an uninsulated portion of the conductor. The medical electrode system may further include an electrical connector attached to a proximal end of the electrical lead, and the electrical connector may be mechanically attached to the tether.
[00010] In some embodiments, the medical electrode system may further include a flexible barb. In some embodiments, the tether includes a core that extends through the electrical lead and the electrode, m some of these embodiments that core does not extend through the barb. In some embodiments of the system, the core is connected to the tissue-piecing guide.
[00011] In some embodiments of the medical electrode system the tissue-piercing guide comprises a needle, and in some of these embodiments, the needle may have a flared proximal end and a sharp distal end In some embodiments of medical electrode system the core may include a distally terminal knob positioned distal to the electrode; the knob being configured to engage a delivery instrument to facilitate ejection of the electrode from the instrument.
[00012] With regard to the method aspect of the invention, a method of using an electrode in target tissue in a patient includes inserting a tissue-piercing guide into and through the target tissue, pulling an electrode connected to a proximal end of the tissue-piercing guide into the target tissue (the electrode being connected to the tissue-piercing guide by a tether extending distally from the electrode), and extendmg an electrical lead and the tether proximally from the electrode to an electrical connection location. In some embodiments of the method, the electrode includes a barb, and the method includes pulling the barb into the target tissue
[00013] Method embodiments of using the electrode may further include cutting the tether between the electrode and the tissue-piercing guide after the pulling step, and removing the tissue- piercmg guide from the patient. The method may also further include removing the electrode from the target tissue; the removing step may include pulling proximally on the electrical lead and pulling proximally on the tether. In some embodiments of the system, the electrical lead and the tether terminate in an electrical connector, and with these embodiments, the step of removing step may further include removing the electrical connector from the electrical lead and tether. In some embodiments of the system, the electrical lead surrounds at least a portion of the tether, and with these embodiments, the step of removing the electrode may further include separating the electrical lead and the tether prior to the pulling steps.
[00014] In another embodiment of a method for using the electrode system in a target tissue of a patient, the method includes inserting an electrode into the target tissue (the electrode being bonded to a tether and electrically connected to an electrical lead), and extending an electrical lead and the tether proximally from the electrode to an electrical connection location. In some embodiments, the method may further include removing the electrode from the target tissue, in which case the removing step includes pulling proximally on the electrical lead and pulling proximally on the tether. In some embodiments of the system, the electrical lead and tether terminate in an electrical connecter, and in such embodiments the removing step may further include removing the electrical connector from the electrical lead and tether. In some embodiments of the system, the electrical lead surrounds at least a
portion of the tether, and in such embodiments, the removing step may further include separating the electrical lead and the tether prior to the pulling steps.
BRIEF DESCRIPTION OF THE DRAWINGS
[00015] The novel features of the invention are set forth with particularity m the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments in which the principles of the invention are utilized, and by reference to the accompanying drawings.
[00016] Figure 1 is a side elevational view of an intramuscular electrode according to one embodiment of the invention.
[00017] Figure 2 is a side elevational view of an intramuscular electrode according to a second embodiment of the invention.
[00018] Figure 3 is a side elevational view of an intramuscular electrode according to a third embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION
[00019] Data have shown that forces necessary for extraction range from about 0.25N at time of implant to 0.6N after four weeks of implantation. More complex intramuscular helical electrodes (Peterson type) have shown long-term stability, a cumulative total exceedmg 520 implant electrode- years, without fracture, but significantly more force is required to extract them. The extraction force for Peterson type electrodes range from 0.6N at time of implant to 5.8N after four weeks of implantation. The force required to pull apart the heavy barbing of a Peterson type electrode ranges from 4N - 8N. There is a need for therapeutic electrodes that have the structural integrity to resist breakage during extraction, in order to minimize the generation of UDFs, and/or have design features that minimize the force required for their extraction.
[00020] Figure 1 shows one embodiment of an electrode system of this invention, which includes electrode 10 and electrode lead 12 formed from a helically wound insulated conductor. In some other embodiments, two helically interwoven conductors form the lead and electrode. The insulation has been removed from the part of the conductor, thus forming electrode 10, while the insulation covering the lead portion 12 remains intact. Electrode 10 is bent bac^ to form a barb 14 as shown Electrode 10 and lead 12 terminate proximally in a connector 16 that may be connector to an exterior stimulator cable providing stimulation pulses through the lead to the electrode after the electrode has been implanted As shown, connector 16 has a sleeve 18 covering the electrical connection between lead 12 and a connector pin 20. Sleeve 18 may also provide strain relief.
[00021] A tether, formed, for example, as a core 22, is disposed withm the helix of lead 12 and electrode 10 The core 22 may be formed of a variety of materials, for example polypropylene suture material, absorbable suture material or any other suitable material. Core 22 being flexible, it imparts flexibility to the electrode as a whole. Core 22 is pπmaπly attached or bonded to electrode 10, but the core's attachment may extend to or through the length of lead 12. Attachment of the core, at the site of electrode 10, may be performed by a mechanical heating that results m an infiltration and expansion of the core material into the electrode windings. This mechanical fixation results m a structural integrity that can withstand ION of force to pull the core from the electrode, thus significantly reducing or eliminating the generation of unretπeved device fragments upon extraction. In the embodiments shown in figures 1 - 3, the attachment between the core and the electrical lead is achieved by heating the core and electrode so that the polypropylene expands within the helix of electrode 10. In the embodiments shown in figures 1 - 3, core 22 extends only through the portion of the electrode that is in line with lead 12 and does not extend into barb 14. In other embodiments, the core may extend throughout the entire electrode. The electrode may be attached to the core in other ways as well, such as by crimping. The proximal end of core 22 is attached to a connector 16, such as by crimping.
[00022] The electrode of this invention may be delivered and implanted into muscle tissue by any conventional means The embodiments shown in figures 1 - 3 depict an electrode implantation device that is integrated with the electrode and lead. As shown, core 22 extends through and past electrode 10 to a tissue-piercmg guide, such as a needle 30. Needle 30 is attached to core 22 by crimping or by some other suitable means. As shown in figure 1, needle 30 has a curved tip 32 at its distal end to facilitate insertion into and out of muscle, particularly thick muscle.
[00023] As shown, the proximal end of needle 30 has the same diameter as the needle shaft. Alternatively, the proximal end of the needle 30 may be flared to create an opening and facilitate entry of the electrode through the target tissue (such as the epimysium and muscle fibers of the diaphragm).
[00024] The size of the needle depends on the application and/or site to which the electrode is being directed For implantation of a temporary intramuscular electrode in the diaphragm, suitable needle sizes range from 28 gauge to 16 gauge. Other applications may require other needle sizes either larger or smaller. The shaft of needle 30 is typically longer than the length of the de-insulated electrode. For example, for use of an embodiment in the diaphragm, the portion of electrode 10 in line with lead 12 may have a length of about 10 mm, while barb 14 may have a length of about 5 mm. In this embodiment, the shaft of needle 30 may be about 20 mm long, and the curved tip 32 may extend about 2.5 mm up from the needle shaft axis. The portion of core 22 extending past electrode 10 to needle 30 is about 20 mm. Electrical lead 12 must be long enough to extend from the implantation site in the diaphragm to the connector 16 outside of the patient, a length of at least about 300 mm.
[00025] Figure 2 shows another embodiment that includes an implantation needle 30 with a straight tip 34 All other elements of the invention are the same as the figure 1 embodiment and are labeled accordingly. This straight-tip needle may be used for thinner muscle or for other tissue so that as the needle is inserted into the tissue at a shallow angle, the tip does not emerge from the tissue before a proper distance has been traversed by the needle. Additionally, in other embodiments, the needle may have an alternate shape (such as an intermediate inflection point) to facilitate tissue entry without prematurely emerging from the tissue until an appropriate or sufficient distance has been traversed by the needle
[00026] When implanting the electrode of figure 1 or figure 2 into a target tissue site such as the diaphragm, the needle 30 is inserted and guided laparoscopically into the abdomen below the diaphragm at the desired implant location. (The appropriate electrode implant locations may be determined using the mapping procedure described by Onders, et ai, "Mapping the phrenic nerve motor point' the key to a successful laparoscopic diaphragm pacing system in the first human series " Surgery 136(4). 819-26, 2004.) Implantation may also occur above the diaphragm using thoracoscopic techniques, or it may also occur above or below the diaphragm using open surgical techniques. The curved distal tip 32 of the needle is passed into the diaphragm, and then guided out (like a sewing needle) at a point preferably at least about 10 mm distal to the entry point. The needle is advanced further distally to pull or embed the electrode 10 mto the diaphragm tissue. The heat bonding between core 22 and electrode 10 helps ensure that the electrode will advance into the tissue without sliding back on the lead when encountering tissue resistance. Electrode barb 14 folds back toward the linear axis of the device as the electrode is advanced distally into the tissue, but prevents the electrode from being easily pulled back proximally.
[00027] Connector 16 and the proximal end of lead 12 may be tunneled subcutaneously before exiting through the patient's skin via a needle (or trocar) puncture to provide a connection to an external stimulator. After the electrode is in the desired location in the diaphragm, core 22 may be cut between the proxnnal end of needle 30 and the core's exit point from the diaphragm, and the needle may be removed from the patient.
[00028] Figure 3 shows another embodiment of electrode system that is similar to the embodiments of figures 1 and 2 except that it lacks the implantation needle and has instead a knob 25. All other elements of the device of identical to those of figures 1 and 2 and labeled accordingly. Knob 25 may be formed by melting the distal terminal portion of the core, or it may be formed by any suitable method or foπned of any suitable material such that it is firmly bonded to the core 22 or integral with the core 22 This particular embodiment is appropπate for use in conjunction with a surgical instrument for implanting electrodes such as that described in U.S. Patent No. 5,797,923 of Aiyar and Mortimer In this particular use of the embodiment of the invention, the knob 25 may be
finished flush with the electrode 10 to provide a feature with which the instrument can engage to facilitate ejection of the electrode and lead from the surgical instrument, and in so doing, insert the electrode system into the target site.
[00029] Certain forms of diaphragm pacing may be performed for a finite peπod of time. For example, diaphragm pacing may help wean patients from mechanical ventilation sooner and more easily than could otherwise be weaned. Once diaphragm pacing is no longer needed, removal of the electrode and lead from the patient's diaphragm and abdomen is desired.
[00030] To remove electrode 10 from the patient, connector 16 is first cut off the proximal end of lead 12. Since core 22 is bound to connector 16 but is not bound to the insulated portion of lead 12, cutting off the connector allows the proximal ends of core 22 and lead 12 to be moved independently. Helical lead 12 may then be straightened, or unwound from around the core and pulled proxrmally to dislodge electrode 10 from the tissue. Concurrently, core 22 may be pulled proximally as well, independently of lead 12. The combination of the pulling effects of the lead and the core helps the electrode become dislodged from the tissue despite any encapsulation or fibrosis around the electrode. In addition, the electrode barb 14 may straighten in response to sufficient proximal force to allow the electrode to exit the tissue more easily.
Claims
1. A medical electrode system comprising: an electrode; an electrical lead mechanically and electrically col ected to the electrode and extending proximally from the electrode; and an electrode tether bonded to the electrode and extending proximally from the electrode.
2. The medical electrode system of claim 1 further comprising a tissue-piercing guide attached to a distal end of the electrode.
3. The medical electrode system of claim 2 wherein the tissue-piercing guide comprises a needle having a flared proximal end and a sharp distal end.
4. The medical electrode system of claim 1 wherein the electrical lead surrounds at least a portion of the tether.
5 The medical electrode system of claim 1 wherein the electrical lead comprises an insulated conductor, the electrode comprising an uninsulated portion of the conductor.
6. The medical electrode system of claim 1 further comprising an electπcal connector attached to a proximal end of the electπcal lead.
7. The medical electrode system of claim 6 wherein the electrical connector is mechanically attached to the tether.
8. The medical electrode system of claim 1 wherein the electrode further compπses a flexible barb.
9. The medical electrode system of claim 8 wherein the tether compπses a core extending through the electrical lead and the electrode but not through the barb.
10. The medical electrode system of claim 1 wherein the tether comprises a core extending through the electrical lead and the electrode.
11. The medical electrode system of claim 10 further comprising a tissue-piercing guide attached to the core distal to the distal end of the electrode.
12. The medical electrode system of claim 10 wherein the core includes a distally terminal knob distal to the electrode, the knob configured to engage a delivery instrument to facilitate ejection of the electrode from the instrument.
13. A method of using an electrode in target tissue in a patient, the method comprising: inserting a tissue-piercing guide into and through the target tissue; pulling an electrode connected to a proximal end of the tissue-piercing guide into the target tissue, the electrode being connected to the tissue-piercing guide by a tether extending distally from the electrode, and extending an electrical lead and the tether proximally from the electrode to an electrical connection location.
14 The method of claim 13 wherein the electrode comprises a barb, the method further comprising pulling the barb into the target tissue.
15. The method of claim 13 further comprising cutting the tether between the electrode and the tissue-piercmg guide after the pulling step and removing the tissue-piercing guide from the patient.
16. The method of claim 13 further comprising removing the electrode from the target tissue, the removing step comprising pulling proximally on the electrical lead and pulling proximally on the tether.
17. The method of claim 16 wherein the electrical lead and tether terminate in an electrical connector, the removing step further compπsing removing the electrical connector from the electrical lead and tether.
18. The method of claim 16 wherein the electπcal lead surrounds at least a portion of the tether, the removing step further comprising separating the electπcal lead and the tether prior to the pulling steps.
19. A method of using an electrode in target tissue m a patient, the method compπsing: inserting an electrode into the target tissue, the electrode being bonded to a tether and electrically connected to an electrical lead; and extending an electrical lead and the tether proximally from the electrode to an electrical connection location.
20. The method of claim 19 further comprising removing the electrode from the target tissue, the removing step comprising pulling proximally on the electrical lead and pulling proximally on the tether.
21. The method of claim 20 wherein the electrical lead and tether terminate in an electrical connector, the removing step further comprising removing the electrical connector from the electrical lead and tether.
22. The method of claim 20 wherein the electrical lead surrounds at least a portion of the tether, the removing step further comprising separating the electrical lead and the tether prior to the pulling steps.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89979907P | 2007-02-05 | 2007-02-05 | |
US60/899,799 | 2007-02-05 | ||
US12/026,428 US9079016B2 (en) | 2007-02-05 | 2008-02-05 | Removable intramuscular electrode |
US12/026,428 | 2008-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008098001A2 true WO2008098001A2 (en) | 2008-08-14 |
WO2008098001A3 WO2008098001A3 (en) | 2008-10-09 |
Family
ID=39491691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/053086 WO2008098001A2 (en) | 2007-02-05 | 2008-02-05 | Removable intramuscular electrode |
Country Status (2)
Country | Link |
---|---|
US (1) | US9079016B2 (en) |
WO (1) | WO2008098001A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005009291A2 (en) * | 2003-07-23 | 2005-02-03 | Synapse Biomedical, Inc. | System and method for conditioning a diaphragm of a patient |
US8428726B2 (en) | 2007-10-30 | 2013-04-23 | Synapse Biomedical, Inc. | Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system |
WO2009059033A1 (en) | 2007-10-30 | 2009-05-07 | Synapse Biomedical, Inc. | Method of improving sleep disordered breathing |
US9744349B2 (en) * | 2011-02-10 | 2017-08-29 | Respicardia, Inc. | Medical lead and implantation |
US8972027B2 (en) * | 2011-07-19 | 2015-03-03 | Shalom MANOVA | Implantable medical device including electrode element, anchoring element and elastic element |
RU2499549C1 (en) * | 2012-08-02 | 2013-11-27 | Максим Евгеньевич Николаев | T-shaped monopolar needle electrode for registration of electric activity of gastrointestinal tract organs of animals |
US20140276986A1 (en) * | 2013-03-15 | 2014-09-18 | Carine Hoarau | Anastomotic device and method |
AU2019369511A1 (en) * | 2018-11-01 | 2021-05-27 | Incube Labs, Llc | Device, systems and methods for treatment of neurogenic bladder |
US11471683B2 (en) | 2019-01-29 | 2022-10-18 | Synapse Biomedical, Inc. | Systems and methods for treating sleep apnea using neuromodulation |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5797923A (en) * | 1997-05-12 | 1998-08-25 | Aiyar; Harish | Electrode delivery instrument |
US20030040785A1 (en) * | 2001-08-21 | 2003-02-27 | Maschino Steve E. | Circumneural electrode assembly |
US20050033394A1 (en) * | 2003-08-08 | 2005-02-10 | Medtronic, Inc. | Medical electrical lead anchoring |
WO2005039691A1 (en) * | 2003-10-24 | 2005-05-06 | Cardiac Pacemakers, Inc. | Myocardial lead attachment system |
US20050107812A1 (en) * | 2002-06-13 | 2005-05-19 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
WO2007128002A2 (en) * | 2006-04-28 | 2007-11-08 | Medtronic, Inc. | Implantable medical lead assemblies with delivery tether |
Family Cites Families (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1693734A (en) | 1923-06-29 | 1928-12-04 | Mcintosh Electrical Corp | Switching means for effecting electrotherapeutic treatment |
US2532788A (en) | 1948-01-03 | 1950-12-05 | Stanley J Sarnoff | Artificial respiration by electronic stimulation |
US2664880A (en) | 1951-11-23 | 1954-01-05 | Jr Nathaniel B Wales | Electric stimulator for artificial respiration |
US6210970B1 (en) | 1980-01-14 | 2001-04-03 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
US6194217B1 (en) | 1980-01-14 | 2001-02-27 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
US4699875A (en) | 1982-11-24 | 1987-10-13 | Baylor College Of Medicine | Diagnosis of amyotrophic lateral sclerosis by neurotrophic factors |
FR2566276B1 (en) | 1984-06-21 | 1988-07-08 | Medtronic Bv | DIAPHRAGMATIC STIMULATION METHOD AND APPARATUS |
US4863438A (en) | 1985-11-29 | 1989-09-05 | Applied Medical Technology, Inc. | Low profile gastrostomy device |
US4827935A (en) | 1986-04-24 | 1989-05-09 | Purdue Research Foundation | Demand electroventilator |
US4773393A (en) | 1986-07-03 | 1988-09-27 | C. R. Bard, Inc. | Hypodermically implantable genitourinary prosthesis |
US4830008A (en) | 1987-04-24 | 1989-05-16 | Meer Jeffrey A | Method and system for treatment of sleep apnea |
US5368035A (en) | 1988-03-21 | 1994-11-29 | Boston Scientific Corporation | Ultrasound imaging guidewire |
US4989617A (en) | 1989-07-14 | 1991-02-05 | Case Western Reserve University | Intramuscular electrode for neuromuscular stimulation system |
US5056519A (en) | 1990-05-14 | 1991-10-15 | Vince Dennis J | Unilateral diaphragmatic pacer |
US5074846A (en) | 1990-09-13 | 1991-12-24 | Abbott Laboratories | Stoma creator gastrostomy device and method for placement of a feeding tube |
US5146918A (en) | 1991-03-19 | 1992-09-15 | Medtronic, Inc. | Demand apnea control of central and obstructive sleep apnea |
US5335657A (en) | 1991-05-03 | 1994-08-09 | Cyberonics, Inc. | Therapeutic treatment of sleep disorder by nerve stimulation |
US5241957A (en) | 1991-11-18 | 1993-09-07 | Medtronic, Inc. | Bipolar temporary pacing lead and connector and permanent bipolar nerve wire |
US7429262B2 (en) | 1992-01-07 | 2008-09-30 | Arthrocare Corporation | Apparatus and methods for electrosurgical ablation and resection of target tissue |
CA2137666A1 (en) | 1992-06-12 | 1993-12-23 | Stanley H. Appel | Method and kit for diagnosing amyotrophic lateral sclerosis |
US5843641A (en) | 1993-02-26 | 1998-12-01 | Massachusetts Institute Of Technology | Methods for the daignosis, of familial amyotrophic lateral sclerosis |
US5813399A (en) | 1993-03-16 | 1998-09-29 | Puritan Bennett Corporation | System and method for closed loop airway pressure control during the inspiratory cycle of a breath in a patient ventilator using the exhalation valve as a microcomputer-controlled relief valve |
US5792165A (en) | 1993-07-21 | 1998-08-11 | Charles H. Klieman | Endoscopic instrument with detachable end effector |
US5472438A (en) | 1993-07-22 | 1995-12-05 | Case Western Reserve University | Laproscopic vacuum delivery apparatus for a diaphragm daper |
US5429636A (en) | 1993-10-08 | 1995-07-04 | United States Surgical Corporation | Conductive body tissue penetrating device |
US5524632A (en) | 1994-01-07 | 1996-06-11 | Medtronic, Inc. | Method for implanting electromyographic sensing electrodes |
US5527358A (en) | 1994-01-21 | 1996-06-18 | Medtronic, Inc. | Temporary medical electrical lead |
US5718248A (en) | 1994-04-15 | 1998-02-17 | Allegheny-Singer Research Institute | Muscle energy converter pump and method of pumping fluid of a patient |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
US5483969A (en) | 1994-09-21 | 1996-01-16 | Medtronic, Inc. | Method and apparatus for providing a respiratory effort waveform for the treatment of obstructive sleep apnea |
US5678535A (en) | 1995-04-21 | 1997-10-21 | Dimarco; Anthony Fortunato | Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient |
US5591216A (en) | 1995-05-19 | 1997-01-07 | Medtronic, Inc. | Method for treatment of sleep apnea by electrical stimulation |
US6198970B1 (en) | 1995-10-27 | 2001-03-06 | Esd Limited Liability Company | Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation |
US5716392A (en) | 1996-01-05 | 1998-02-10 | Medtronic, Inc. | Minimally invasive medical electrical lead |
EP0888086B1 (en) | 1996-02-15 | 2005-07-27 | Biosense Webster, Inc. | Excavation probe |
US7225019B2 (en) * | 1996-04-30 | 2007-05-29 | Medtronic, Inc. | Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure |
SE9603841D0 (en) | 1996-10-18 | 1996-10-18 | Pacesetter Ab | A tissue stimulating apparatus |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6035856A (en) | 1997-03-06 | 2000-03-14 | Scimed Life Systems | Percutaneous bypass with branching vessel |
US6477423B1 (en) | 1997-05-28 | 2002-11-05 | Transneuronix, Inc. | Medical device for use in laparoscopic surgery |
US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
ATE353689T1 (en) | 1997-07-16 | 2007-03-15 | Metacure Nv | DEVICE FOR CONTROLLING A SMOOTH MUSCLE |
US7165551B2 (en) | 1998-02-19 | 2007-01-23 | Curon Medical, Inc. | Apparatus to detect and treat aberrant myoelectric activity |
US6845271B2 (en) | 1998-06-03 | 2005-01-18 | Neurocontrol Corporation | Treatment of shoulder dysfunction using a percutaneous intramuscular stimulation system |
US6463327B1 (en) | 1998-06-11 | 2002-10-08 | Cprx Llc | Stimulatory device and methods to electrically stimulate the phrenic nerve |
US6213960B1 (en) | 1998-06-19 | 2001-04-10 | Revivant Corporation | Chest compression device with electro-stimulation |
SE9803508D0 (en) | 1998-10-14 | 1998-10-14 | Siemens Elema Ab | Assisted Breathing System |
US6245053B1 (en) | 1998-11-09 | 2001-06-12 | Medtronic, Inc. | Soft tip guiding catheter and method of fabrication |
US6645145B1 (en) | 1998-11-19 | 2003-11-11 | Siemens Medical Solutions Usa, Inc. | Diagnostic medical ultrasound systems and transducers utilizing micro-mechanical components |
ES2243282T3 (en) | 1999-06-30 | 2005-12-01 | University Of Florida Research Foundation, Inc. | FAN MONITORING SYSTEM. |
US7526342B2 (en) | 1999-08-10 | 2009-04-28 | Maquet Cardiovascular Llc | Apparatus for endoscopic cardiac mapping and lead placement |
US7206636B1 (en) | 1999-11-10 | 2007-04-17 | Pacesetter, Inc. | Pacing optimization based on changes in pulse amplitude and pulse amplitude variability |
US6689062B1 (en) | 1999-11-23 | 2004-02-10 | Microaccess Medical Systems, Inc. | Method and apparatus for transesophageal cardiovascular procedures |
US6254425B1 (en) * | 1999-11-30 | 2001-07-03 | Ethicon, Inc. | Electrical connector for cardiac devices |
US6415183B1 (en) | 1999-12-09 | 2002-07-02 | Cardiac Pacemakers, Inc. | Method and apparatus for diaphragmatic pacing |
AU2001257582A1 (en) | 2000-03-14 | 2001-09-24 | Children's Medical Center Corporation, The | Method for improving respiratory function and inhibiting muscular degeneration |
AU2001249308A1 (en) | 2000-03-24 | 2001-10-15 | Johns Hopkins University | Peritoneal cavity device and method |
US6397108B1 (en) | 2000-04-03 | 2002-05-28 | Medtronic Inc. | Safety adaptor for temporary medical leads |
US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US20030148404A1 (en) | 2000-07-27 | 2003-08-07 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
EP2151187A1 (en) | 2000-08-21 | 2010-02-10 | The General Hospital Corporation | Methods for diagnosing a neurodegenerative condition |
JP2004517634A (en) | 2000-10-27 | 2004-06-17 | ベイラー カレッジ オブ メディシン | Methods and compositions for identification and treatment of neurodegenerative diseases |
SE0004141D0 (en) | 2000-11-13 | 2000-11-13 | Siemens Elema Ab | Method of adaptive triggering of breathing devices and a breathing device |
US6754536B2 (en) | 2001-01-31 | 2004-06-22 | Medtronic, Inc | Implantable medical device affixed internally within the gastrointestinal tract |
FR2822238B1 (en) | 2001-03-16 | 2003-08-29 | Gemac | METHOD AND KIT FOR MONITORING NEURODEGENERATIVE DISEASES |
US20050019915A1 (en) | 2001-06-21 | 2005-01-27 | Bennett C. Frank | Antisense modulation of superoxide dismutase 1, soluble expression |
US20050171579A1 (en) | 2001-11-09 | 2005-08-04 | Claudia Tasche | Stimulating device |
JP2005510524A (en) | 2001-11-16 | 2005-04-21 | アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド | Treatment of neurodegenerative disorders by modulating the polyamine pathway |
AU2003219788A1 (en) | 2002-02-13 | 2003-09-04 | Dana-Farber Cancer Institute, Inc. | METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1Alpha- |
US7166075B2 (en) | 2002-03-08 | 2007-01-23 | Wisconsin Alumni Research Foundation | Elastographic imaging of in vivo soft tissue |
US7463934B2 (en) | 2002-04-12 | 2008-12-09 | Medtronic, Inc. | Implantable medical device with captivation fixation |
US7207946B2 (en) | 2002-05-09 | 2007-04-24 | Spiration, Inc. | Automated provision of information related to air evacuation from a chest cavity |
SE0202537D0 (en) | 2002-08-28 | 2002-08-28 | Siemens Elema Ab | Nerve stimulation apparatus |
JP2006508707A (en) | 2002-09-04 | 2006-03-16 | ワシントン・ユニバーシティ | Treatment of central nervous system injury |
US20040064069A1 (en) | 2002-09-30 | 2004-04-01 | Reynolds Brian R. | Medical device with support member |
US20060041022A1 (en) | 2002-11-06 | 2006-02-23 | Pasinetti Giulio M | Treatment of amyotrophic lateral sclerosis with nimesulide |
WO2004052456A1 (en) | 2002-12-09 | 2004-06-24 | Medtronic, Inc. | Modular implantable medical device |
US6945956B2 (en) | 2002-12-23 | 2005-09-20 | Medtronic, Inc. | Steerable catheter |
WO2004069174A2 (en) | 2003-01-31 | 2004-08-19 | Slil Biomedical Corporation | Monitoring and treatment of amyotrophic lateral sclerosis |
US7044921B2 (en) | 2003-02-03 | 2006-05-16 | Scimed Life Systems, Inc | Medical device with changeable tip flexibility |
US20040167437A1 (en) | 2003-02-26 | 2004-08-26 | Sharrow James S. | Articulating intracorporal medical device |
US7182735B2 (en) | 2003-02-26 | 2007-02-27 | Scimed Life Systems, Inc. | Elongated intracorporal medical device |
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US20040254419A1 (en) | 2003-04-08 | 2004-12-16 | Xingwu Wang | Therapeutic assembly |
US7155278B2 (en) | 2003-04-21 | 2006-12-26 | Medtronic, Inc. | Neurostimulation to treat effects of sleep apnea |
US20040254572A1 (en) | 2003-04-25 | 2004-12-16 | Mcintyre Jon T. | Self anchoring radio frequency ablation array |
GB0309916D0 (en) | 2003-04-30 | 2003-06-04 | Ares Trading Sa | Secreted protein family |
US20060287679A1 (en) | 2003-05-16 | 2006-12-21 | Stone Robert T | Method and system to control respiration by means of confounding neuro-electrical signals |
US20060064137A1 (en) | 2003-05-16 | 2006-03-23 | Stone Robert T | Method and system to control respiration by means of simulated action potential signals |
US20060111755A1 (en) | 2003-05-16 | 2006-05-25 | Stone Robert T | Method and system to control respiration by means of neuro-electrical coded signals |
US7738952B2 (en) | 2003-06-09 | 2010-06-15 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system |
US20040260337A1 (en) | 2003-06-18 | 2004-12-23 | Scimed Life Systems, Inc. | Endoscopic instruments and methods of manufacture |
US8469993B2 (en) | 2003-06-18 | 2013-06-25 | Boston Scientific Scimed, Inc. | Endoscopic instruments |
US6918871B2 (en) | 2003-06-19 | 2005-07-19 | Ethicon Endo-Surgery, Inc. | Method for accessing cavity |
US7824368B2 (en) | 2003-06-19 | 2010-11-02 | Ethicon Endo-Surgery, Inc. | Method for endoscopic, transgastric access into the abdominal cavity |
US8579804B2 (en) | 2003-06-23 | 2013-11-12 | Boston Scientific Scimed, Inc. | Variable length nephrostomy sheath |
WO2005009291A2 (en) | 2003-07-23 | 2005-02-03 | Synapse Biomedical, Inc. | System and method for conditioning a diaphragm of a patient |
EP1660177A4 (en) | 2003-07-23 | 2010-03-03 | Univ Cleveland Hospitals | Mapping probe system for neuromuscular electrical stimulation apparatus |
EP1670547B1 (en) | 2003-08-18 | 2008-11-12 | Cardiac Pacemakers, Inc. | Patient monitoring system |
US7887493B2 (en) | 2003-09-18 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable device employing movement sensing for detecting sleep-related disorders |
US7616988B2 (en) | 2003-09-18 | 2009-11-10 | Cardiac Pacemakers, Inc. | System and method for detecting an involuntary muscle movement disorder |
US8002553B2 (en) | 2003-08-18 | 2011-08-23 | Cardiac Pacemakers, Inc. | Sleep quality data collection and evaluation |
US7641621B2 (en) | 2003-08-25 | 2010-01-05 | Boston Scientific Scimed, Inc. | Elongated intra-lumenal medical device |
US20050054952A1 (en) | 2003-09-05 | 2005-03-10 | Scimed Life Systems, Inc. | Elongated medical device for intracorporal use |
US7833175B2 (en) | 2003-09-05 | 2010-11-16 | Boston Scientific Scimed, Inc. | Medical device coil |
US7540845B2 (en) | 2003-09-05 | 2009-06-02 | Boston Scientific Scimed, Inc | Medical device coil |
US20070122813A1 (en) | 2003-10-03 | 2007-05-31 | David Salomon | Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof |
NO319063B1 (en) | 2003-10-06 | 2005-06-13 | Laerdal Medical As | Medical patient simulator |
US7979128B2 (en) | 2003-10-15 | 2011-07-12 | Rmx, Llc | Device and method for gradually controlling breathing |
US8160711B2 (en) | 2003-10-15 | 2012-04-17 | Rmx, Llc | Multimode device and method for controlling breathing |
US8467876B2 (en) | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
US20060167523A1 (en) | 2003-10-15 | 2006-07-27 | Tehrani Amir J | Device and method for improving upper airway functionality |
US9259573B2 (en) | 2003-10-15 | 2016-02-16 | Rmx, Llc | Device and method for manipulating exhalation |
US8244358B2 (en) | 2003-10-15 | 2012-08-14 | Rmx, Llc | Device and method for treating obstructive sleep apnea |
US7970475B2 (en) | 2003-10-15 | 2011-06-28 | Rmx, Llc | Device and method for biasing lung volume |
CA2542391A1 (en) | 2003-10-23 | 2005-05-12 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Biomarkers for amyotrophic lateral sclerosis |
WO2005048862A2 (en) | 2003-11-18 | 2005-06-02 | Scimed Life Systems, Inc. | System and method for tissue ablation |
US7802571B2 (en) | 2003-11-21 | 2010-09-28 | Tehrani Fleur T | Method and apparatus for controlling a ventilator |
US7237313B2 (en) | 2003-12-05 | 2007-07-03 | Boston Scientific Scimed, Inc. | Elongated medical device for intracorporal use |
US7824345B2 (en) | 2003-12-22 | 2010-11-02 | Boston Scientific Scimed, Inc. | Medical device with push force limiter |
US20050149072A1 (en) | 2003-12-31 | 2005-07-07 | Devries Robert B. | Devices and methods for tissue invagination |
US7519425B2 (en) | 2004-01-26 | 2009-04-14 | Pacesetter, Inc. | Tiered therapy for respiratory oscillations characteristic of Cheyne-Stokes respiration |
US8256419B2 (en) | 2004-02-18 | 2012-09-04 | Maquet Critical Care Ab | Method and device using myoelectrical activity for optimizing a patient's ventilatory assist |
US20050209653A1 (en) | 2004-03-16 | 2005-09-22 | Medtronic, Inc. | Intra-luminal device for gastrointestinal electrical stimulation |
WO2005091716A2 (en) | 2004-03-26 | 2005-10-06 | Quark Biotech, Inc. | Annexin ii and uses thereof |
US7931661B2 (en) | 2004-06-14 | 2011-04-26 | Usgi Medical, Inc. | Apparatus and methods for performing transluminal gastrointestinal procedures |
US7225016B1 (en) | 2004-06-16 | 2007-05-29 | Pacesetter, Inc. | Implantable medical device with nerve signal sensing |
US20060058852A1 (en) | 2004-09-10 | 2006-03-16 | Steve Koh | Multi-variable feedback control of stimulation for inspiratory facilitation |
US20060068452A1 (en) | 2004-09-29 | 2006-03-30 | Power3 Medical Products, Inc. | Differential protein expression patterns related to disease states |
US20060088862A1 (en) | 2004-09-30 | 2006-04-27 | Nancy Lee | Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof |
JP2008523785A (en) | 2004-10-12 | 2008-07-10 | カーランテック,インコーポレーテッド | Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes |
JP4960246B2 (en) | 2004-10-20 | 2012-06-27 | レスメド・リミテッド | A system for detecting inactive expiratory effort in patient-ventilator interactions |
US20060115854A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease |
US20060115856A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | 2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease |
US20060115855A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease |
US20060115867A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | TRIM 5 related protein as a biomarker of neurodegenerative disease |
US20060121619A1 (en) | 2004-12-02 | 2006-06-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
US20060122661A1 (en) | 2004-12-03 | 2006-06-08 | Mandell Lee J | Diaphragmatic pacing with activity monitor adjustment |
US20060130833A1 (en) | 2004-12-16 | 2006-06-22 | Magdy Younes | Treatment of obstructive sleep apnea |
US7356521B2 (en) | 2005-01-14 | 2008-04-08 | Siemens Medical Solutions Usa, Inc. | System and method for automatic molecular diagnosis of ALS based on boosting classification |
US8016839B2 (en) | 2005-01-26 | 2011-09-13 | Wilk Patent, Llc | Intra-abdominal medical procedures and device |
US7729767B2 (en) | 2005-02-15 | 2010-06-01 | Baker Iii Rex M | Implantable generating system |
US20060237023A1 (en) | 2005-04-26 | 2006-10-26 | Usgi Medical Inc. | Transgastric tubal ligation |
US20060270742A1 (en) | 2005-05-02 | 2006-11-30 | Jane Staunton | Compositions and methods for the treatment of neurodegenerative diseases |
EP1879643A1 (en) | 2005-05-13 | 2008-01-23 | Science Medicus, Inc. | Method and system to control respiration by means of neuro-electrical coded signals |
US20070054852A1 (en) | 2005-05-27 | 2007-03-08 | Junyu Lin | Compositions and methods of use of Semaphorin 3F and antagonists thereof in the stimulation of neuromuscular regeneration and treatment of muscular diseases |
WO2006130775A2 (en) | 2005-06-01 | 2006-12-07 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
US8364455B2 (en) | 2005-06-09 | 2013-01-29 | Maquet Critical Care Ab | Simulator for use with a breathing-assist device |
US8036750B2 (en) | 2005-06-13 | 2011-10-11 | Cardiac Pacemakers, Inc. | System for neural control of respiration |
US7896848B2 (en) | 2005-06-29 | 2011-03-01 | Samvel Artavazovich Charukhchian | Ostomy tube device, ostomy placement kit and method for an ostomy tube placement |
US20070021500A1 (en) | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
US20070017809A1 (en) | 2005-07-21 | 2007-01-25 | Power3 Medical Products, Inc. | Assay for ALS and ALS-like disorders |
US20070021421A1 (en) | 2005-07-25 | 2007-01-25 | Hampton Thomas G | Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis |
DK2407486T3 (en) | 2005-08-19 | 2018-02-19 | Wyeth Llc | Antagonist antibodies to GDF-8 and uses in the treatment of ALS and other GDF-8-associated disorders |
US9050005B2 (en) | 2005-08-25 | 2015-06-09 | Synapse Biomedical, Inc. | Method and apparatus for transgastric neurostimulation |
SI1933821T1 (en) | 2005-09-15 | 2020-11-30 | Ptc Therapeutics, Inc. | Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
CN101454041B (en) | 2005-09-20 | 2012-12-12 | 呼吸科技公司 | Systems, methods and apparatus for respiratory support of a patient |
US20070202515A1 (en) | 2005-10-12 | 2007-08-30 | Pathologica, Llc. | Promac signature application |
WO2007058938A2 (en) | 2005-11-10 | 2007-05-24 | Inspiration Medical, Inc. | Diaphragm stimulation device |
US7747324B2 (en) | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
CA2865410C (en) | 2005-11-18 | 2022-04-26 | Mark Gelfand | System and method to modulate phrenic nerve to prevent sleep apnea |
CN101495177A (en) | 2005-12-02 | 2009-07-29 | 突触生物医学有限公司 | Transvisceral neurostimulation mapping device and method |
US20070202537A1 (en) | 2005-12-05 | 2007-08-30 | Prosetta Corporation | Biomarkers for als |
US7672728B2 (en) | 2005-12-28 | 2010-03-02 | Cardiac Pacemakers, Inc. | Neural stimulator to treat sleep disordered breathing |
US8281792B2 (en) | 2005-12-31 | 2012-10-09 | John W Royalty | Electromagnetic diaphragm assist device and method for assisting a diaphragm function |
WO2007082384A1 (en) | 2006-01-19 | 2007-07-26 | Maquet Critical Care Ab | Method and system for determining dynamically respiratory features in spontaneously breathing patients receiving mechanical ventilatory assist |
US7347695B2 (en) | 2006-02-03 | 2008-03-25 | Ware Linda M | Chronic obstructive pulmonary disease simulator |
WO2007098367A2 (en) | 2006-02-16 | 2007-08-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Method and apparatus for stimulating a denervated muscle |
US20070197932A1 (en) | 2006-02-17 | 2007-08-23 | Feke Gilbert T | Non-invasive methods for evaluating retinal affecting neurodegenerative diseases |
EP1986636B1 (en) | 2006-02-22 | 2013-04-24 | Edison Pharmaceuticals, Inc. | Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases |
WO2007100782A2 (en) | 2006-02-28 | 2007-09-07 | Metabolon, Inc. | Biomarkers for amyotrophic lateral sclerosis and methods using the same |
EP2495327B1 (en) | 2006-03-03 | 2016-09-28 | ProMIS Neurosciences Inc. | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
US8676323B2 (en) | 2006-03-09 | 2014-03-18 | Synapse Biomedical, Inc. | Ventilatory assist system and methods to improve respiratory function |
US7810497B2 (en) | 2006-03-20 | 2010-10-12 | Ric Investments, Llc | Ventilatory control system |
US7900626B2 (en) | 2006-04-17 | 2011-03-08 | Daly Robert W | Method and system for controlling breathing |
EP2023718A4 (en) | 2006-05-11 | 2010-04-21 | Avicena Group Inc | Creatine-ligand compounds and methods of use thereof |
EP2023914A4 (en) | 2006-05-11 | 2009-11-11 | Avicena Group Inc | Methods of treating a neurological disorder with creatine monohydrate |
US20070282388A1 (en) | 2006-06-01 | 2007-12-06 | Reuven Sandyk | Method and apparatus for treatment of amyotrophic lateral sclerosis patients |
US8428726B2 (en) | 2007-10-30 | 2013-04-23 | Synapse Biomedical, Inc. | Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system |
-
2008
- 2008-02-05 WO PCT/US2008/053086 patent/WO2008098001A2/en active Application Filing
- 2008-02-05 US US12/026,428 patent/US9079016B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5797923A (en) * | 1997-05-12 | 1998-08-25 | Aiyar; Harish | Electrode delivery instrument |
US20030040785A1 (en) * | 2001-08-21 | 2003-02-27 | Maschino Steve E. | Circumneural electrode assembly |
US20050107812A1 (en) * | 2002-06-13 | 2005-05-19 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US20050033394A1 (en) * | 2003-08-08 | 2005-02-10 | Medtronic, Inc. | Medical electrical lead anchoring |
WO2005039691A1 (en) * | 2003-10-24 | 2005-05-06 | Cardiac Pacemakers, Inc. | Myocardial lead attachment system |
WO2007128002A2 (en) * | 2006-04-28 | 2007-11-08 | Medtronic, Inc. | Implantable medical lead assemblies with delivery tether |
Non-Patent Citations (1)
Title |
---|
NARENDRA BHADRA ET AL: "Extraction Force and Tissue Change During Removal of a Tined Intramuscular Electrode from Rat Gastrocnemius" ANNALS OF BIOMEDICAL ENGINEERING, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 34, no. 6, 12 May 2006 (2006-05-12), pages 1042-1050, XP019389754 ISSN: 1573-9686 cited in the application * |
Also Published As
Publication number | Publication date |
---|---|
US20080188867A1 (en) | 2008-08-07 |
WO2008098001A3 (en) | 2008-10-09 |
US9079016B2 (en) | 2015-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9079016B2 (en) | Removable intramuscular electrode | |
EP2024013B1 (en) | Implantable medical lead assemblies with delivery tether | |
EP2854669B1 (en) | Percutaneous implantation kit for an electrical stimulation lead for stimulating dorsal root ganglion | |
US9782580B2 (en) | Percutaneously implantable paddle-type lead and methods and devices for deployment | |
EP2675520B1 (en) | Systems and methods for implanting paddle lead assemblies of electrical stimulation systems | |
US6459937B1 (en) | Endocardial pacing lead with detachable tip electrode assembly | |
US10369354B2 (en) | Systems and method for anchoring a lead for neurostimulation of a target anatomy | |
US20110251661A1 (en) | Lead fixation and extraction | |
EP0622089A2 (en) | Crush resistant, multi-conductor lead body | |
EP1539295A2 (en) | Cochlear implant electrode and method of making same | |
JP2007505699A (en) | Fixing medical electrical leads | |
WO2000067836A1 (en) | Temporary pacing wire anchor | |
WO2013154754A1 (en) | Systems, devices, and methods for distal fixation of a medical device | |
US9533141B2 (en) | Electrical stimulation leads and systems with elongate anchoring elements | |
US20130245739A1 (en) | Self-anchored stimulator lead and method of insertion | |
US9669210B2 (en) | Electrical stimulation leads and systems with folding anchoring units and methods of making and using | |
WO2000061222A1 (en) | Gastric stimulator apparatus and method for installing | |
US11464987B2 (en) | Implantable medical device and delivery catheter apparatus system and method | |
WO2010141929A1 (en) | Intrathoracic pacemaker | |
WO2001064282A1 (en) | Temporary pacemaker lead | |
WO2024044339A1 (en) | Injectrode system | |
EP2226096B1 (en) | Electrical connector for conveying an electrical signal from a device to an organ of a human or animal body | |
AU2020270117A1 (en) | Anchor system for retaining a device in tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08729078 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08729078 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |